Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07127705 · ClinicalTrials.gov registry record · NA
Rapid Response of Stem Cells and Immune Cells for Efficacy
A NA study of Stem Cell Surveillance, sponsored by Natural Immune Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07127705 is a NA study of Stem Cell Surveillance that is actively recruiting participants, run by Natural Immune Systems. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07127705, a NA study of Stem Cell Surveillance, is actively recruiting participants, sponsored by Natural Immune Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Chaga Mushroom
- DIETARY_SUPPLEMENT Ginseng extract
- DIETARY_SUPPLEMENT Olive extract
- DIETARY_SUPPLEMENT Potassium Hydrogen Glucarate
Study Locations (1)
Oregon
- NIS Labs - Klamath Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2025-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07127705
The ClinicalTrials.gov registry entry for NCT07127705 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stem Cell Surveillance appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT07127705 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT07127705 about?
NCT07127705 is a clinical study titled "Rapid Response of Stem Cells and Immune Cells for Efficacy". The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.
What is the current status of trial NCT07127705?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-05-21. Estimated completion is 2025-10-03.
What conditions does trial NCT07127705 study?
This clinical trial studies the following conditions: Stem Cell Surveillance.
What interventions are being tested in trial NCT07127705?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Chaga Mushroom (DIETARY_SUPPLEMENT), Ginseng extract (DIETARY_SUPPLEMENT), Olive extract (DIETARY_SUPPLEMENT), Potassium Hydrogen Glucarate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07127705?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07127705 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.